Object. The cavernous sinus and surrounding regions-specifically the Meckel cave, posterior sector of the cavernous sinus itself, and the upper part of the petroclival region-are the location of a large variety of lesions that require individual consideration regarding treatment strategy. These regions may be reached for biopsy by a percutaneous needle inserted through the foramen ovale. The aim of this retrospective study was to evaluate the diagnostic accuracy of percutaneous biopsy in a consecutive series of 50 patients referred for surgery between 1991 and 2010.
A lArge variety of lesions may develop in the cavernous sinus region and surrounding area such as tumors (some of them nonsurgical) or pseudotumors of inflammatory origin. Sometimes imaging is not evocative enough to ascertain pathological diagnosis. Percutaneous biopsy through the foramen ovale route may then be performed to aid therapeutic decision-making, thus avoiding unnecessary open surgery when lesions are confirmed to be nonsurgical or nonresectable. In such cases, a biopsy is crucial to allow appropriate medical treatment or chemotherapy and/or radiation therapy. 15 To our knowledge, the first attempt of middle fossa biopsy through the foramen ovale was reported by Stechison and Bernstein 18 in 1989. The method was then used to diagnose and orientate the treatment of lesions located in the parasellar region. 6, 8, 15, 22 The transforaminal route through the foramen ovale was first described by Härtel 11 in 1912 as a route for alcohol injection to treat trigeminal neuralgia. This route was then extensively used with the same indication for electrocoagulation, 12 thermocoagulation, 19 balloon compression, 13 and glycerol injection. 10 It was also used for inserting electroencephalography recording electrodes in the vicinity of the temporomesial region for temporal lobe epilepsy exploration. 21 Given our favorable experience of using Härtel's approach for treating trigeminal neuralgia with the thermorhizotomy procedure in 3800 patients, in terms of accuracy and safety, 16, 17 we adopted this percutaneous route for performing biopsy of the parasellar region and surrounding area. 15 Lesions that were reachable were those located in the Meckel cave, posterior part of the cavernous sinus, and upper part of the petroclival region. This retrospective study aimed to evaluate the diagnostic accuracy of this method in 50 patients harboring lesions in those regions to indicate appropriate treatment.
Methods

Inclusion Criteria
Percutaneous biopsy was considered for those patients who presented with lesions of the central base of the skull located in the Meckel cave, posterior part of the cavernous sinus, or upper part of the petroclival region. The patients chosen to undergo percutaneous biopsy were only those for whom both imaging and clinical parameters did not provide sufficient information on the pathological diagnosis for choosing a treatment course. All patients were treated between 1991 and 2010 at the Department of Neurosurgery of Pierre Wertheimer Hospital, Lyon, France, by the senior neurosurgeon (M.S.). The first 13 patients in this study were previously included in a report detailing the feasibility and safety of this procedure published in 1997.
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Preoperative Evaluation
All patients were evaluated preoperatively using MR imaging, high-resolution CT scan with bone window, and intracranial selective DS angiography by femoral arterial catheterization. The MR imaging evaluation used both T1-and T2-weighted images, with and without contrast enhancement, in the sagittal, coronal, and axial planes to provide information about the mass extent and its relationships to the neurovascular structures, especially the ICA. The CT scan with 3D reconstruction provided information regarding central skull base and middle fossa bone structures, especially the integrity and diameter of the foramen ovale. It was considered of paramount importance to detect any bone defect at the level of the floor of the middle fossa, as this eventually would create a serious risk of injury to the ICA. Selective DS angiography aimed to detail tumor vascularization, its feeders, and its relationships with the ICA. The preoperative evaluation also included neurootological and ophthalmological examinations.
Operative Procedure
Surgical Technique. Patients were placed supine, with the head under fluoroscopic control. Surgery was performed under small-dose and short-lasting general anesthesia with intravenous propofol (Zeneca Pharma), without the need of a laryngeal tube. A local anesthetic with 10 ml of 1% lidocaine was also given at the site of the skin puncture of the cheek, up to the pterygomaxillary fossa. In our early practice, the biopsy needle was a Tuohy 14-gauge needle (Cordis S.A.). 15 Subsequently, we used a newly designed biopsy needle (Sindou biopsy needle ACS-976, DIXI Microtechniques SAS; Fig. 1 ).
The trajectory used for this procedure was the same one widely used for treatment of trigeminal neuralgia, as described by Härtel. 2, 16, 17, 19 The entry point was 3 cm lateral to the labial commissure. The tip of the needle was directed to reach the foramen ovale 3 cm anterior to the tragus on a horizontal line corresponding to the inferior border of the zygoma and the pupilla. Depth was checked under fluoroscopy.
Extreme care must be taken to avoid a wrong trajec-
tory. An excessive posterolateral direction could puncture the internal jugular vein at the jugular foramen, or the ICA at its entrance in the petrous canal. An excessive medial direction could enter the foramen lacerum and injure the ICA at its C-5 segment. An excessive anterior direction could penetrate the orbital apex through the inferior orbital fissure and injure the optic nerve. Along the correct trajectory, the needle may encounter successively the parotid duct, maxillary artery and branches, or auditory tube, with the consequences of hemosialorrhea, cheek hematoma, or middle ear hemoserous otitis, respectively.
After crossing the foramen ovale and Meckel trigeminal cave, light-staged aspirations with the inner cannula connected to the syringe should check for the absence of CSF and/or blood. The needle tip location was confirmed by a lateral view radiograph (Fig. 1) . The needle was then connected to a 20-ml syringe through which negative pressure was manually applied until tissue for cytological and histological examination was obtained.
Harvesting Techniques. Upon harvesting, a small amount of material specimen was sent for immediate pathological examination with the aim to first orientate the biopsy procedure. Staining was conducted using MayGrunwald or toluidine blue. Further biopsy manipulation was discontinued if the pathologist found interpretable pathological tissue, but only after a sufficient quantity of tissue had been harvested for the definitive pathological examination. The immediate pathological examination also aimed to obtain additional information, including indication of the presence of or lack of pathological tissue, orienting the clinical diagnosis toward benign or malig- For the outer needle, the cannula is 10-cm long with 14-gauge diameter. The 16-gauge inner stylet is used for puncturing. The inner needle used to aspirate tissue samples has a 16-gauge cannula. After the outer needle (together with the inner stylet) has been introduced and reached the targeted region, the stylet is withdrawn. The inner needle is then placed inside the outer needle, and is connected to a 20-ml syringe. Tissue samples are aspirated with a strong negative pressure applied to the syringe. Star = maxillosinus angle; solid line = clivus; dashed line = superior border of petrous bone; arrows = foramen ovale.
nant features, and suggesting the histological typology of the lesions.
Pathological Studies. Most of the harvested tissue was kept for standard definitive examination. The cytological specimens were studied using the May-Grunwald staining technique, either directly or after centrifugation. On those occasions when tissue samples were large enough, conventional histological techniques were used and, when possible, a study of immunological markers was added.
Patient Therapeutic Management
Patients were classified into the following different groups according to biopsy results. Group I corresponded to those patients whose biopsy was unproductive, meaning that the pathologist did not obtain workable tumoral tissue because samples contained only coagulum, CSF, or fat tissue; further open craniotomy was necessary to make a diagnosis. Group II corresponded to those patients in whom biopsy was productive, meaning that the pathologist had sufficient tumoral tissue to perform a viable examination. Treatment in these patients was decided upon according to the information gained from the percutaneous biopsy. Treatment options were secondary resective surgery ( 
Statistical Analysis
To define patient characteristics, medical records were reviewed. Diagnostic accuracy for distinguishing between benign and malignant tumors was calculated only in patients who underwent secondary open surgery. The pathological diagnosis provided by the percutaneous biopsy was compared with the pathological diagnosis after open surgery. Given that their long-term prognosis is good, meningiomas, epidermoid cysts, pituitary adenomas, schwannomas, as well as low-grade chondrosarcomas were considered benign tumors. Conversely, melanomas, plasmacytomas, rhabdomyosarcomas, carcinomas, adenocarcinomas, lymphomas, and high-grade chondrosarcomas were considered malignant tumors.
We calculated the sensitivity, specificity, and positive and negative likelihood ratios of the biopsy procedure for differentiating between benign and malignant tumors using a 2 × 2 contingency table (see Appendix). A Bayesian graph showing pretest and posttest probabilities according to the results of the biopsy was constructed using Microsoft Excel 2007.
Concordance between diagnosis at biopsy and diagnosis at open craniotomy was analyzed using the k coefficient (see Appendix). This coefficient varies from 0 to 1, and shows poor concordance when it is below 0.2, moderate concordance when it is between 0.2 and 0.6, good concordance when it is between 0.61 and 0.8, and excellent concordance when it is above 0.81.
Results
This series included 50 consecutive patients who met the inclusion criteria for percutaneous biopsy, namely those in whom imaging features of the lesion, together with the clinical background, did not prove sufficient evidence for establishing a pathological diagnosis. This cohort represents only 16.3% of the 306 patients referred to the senior author (M.S.) during the same period (1991-2010). The 306 patients in the entire series included 194 with cavernous sinus and 37 with petroclival meningiomas, 18 with chordomas or chondrosarcomas, 7 with epidermoid cysts, 7 with lymphomas, 32 with carcinomas, and 11 with miscellaneous other lesions. Masses revealed to be meningiomas (14) , schwannomas (2), and epidermoid cysts (3) by the percutaneous biopsy had been submitted to the procedure because of atypical imaging features, especially heterogeneity. The 5 inflammatory pseudotumors underwent biopsy because of lack of clinical and biological signature. The 13 malignant tumors needed to be confirmed malignancies and characterized before we chose the best modalities of chemotherapy and/ or radiation therapy.
Demographics
The 50 patients included 22 men (44%) and 28 women (56%). Median age was 57 years (range 22-83 years). Twenty-six biopsies (52%) were performed on the left side and 24 (48%) on the right side.
Clinical Presentation
Symptoms at presentation are displayed in Table 1 . Those most commonly observed were trigeminal neuralgia (50%) and diplopia from abducent nerve palsy (24%). Among the 25 patients suffering from trigeminal neuralgia, pathologies consisted of 8 meningiomas (32%), 6 carcinomas (24%), 3 schwannomas (12%), 2 lymphomas (8%), 2 epidermoid cysts (8%), 1 chondrosarcoma (4%), 1 adenocarcinoma (4%), 1 melanoma (4%), and 1 rhabdomyo sarcoma (4%). There were 48% benign and 52% malig nant tumors.
Patient Management
Therapeutic management of the 50 patients is detailed in the flow-diagram in Figure 6 . In 7 patients (14%), biopsies were unproductive (Group I), and therefore, an open craniotomy had to be performed. Secondary diagnosis at open surgery consisted of 2 lymphomas, 2 meningiomas, 1 lipoma, 1 schwannoma, and 1 prolactinoma.
In 43 patients biopsies were productive (Group II). Twenty-four (56%) of the 43 patients were elected to receive resective surgery. Diagnosis at the time of the percutaneous biopsy was meningioma in 12 patients, pituitary adenoma in 2, epidermoid cyst in 2, chondrosarcoma in 4, sarcoma in 1, schwannoma in 1, malignant tumor in 1, and carcinoma in 1. The latter 2 patients were submitted to surgery because the pathologists could not be certain of the precise nature of the specimen. Of the 24 surgical cases, 2 were still on the waiting list for surgery at the time of the present study (2 chondrosarcomas). The other 22 were subject to open craniotomy. The diagnosis of tumor type was confirmed in 17 patients (77%) and was found to be erroneous in 3 (14%): the 2 meningiomas at the time of biopsy were actually rhabdomyosarcoma for one and plasmacytoma for the other, and the low-grade chondrosarcoma was actually an epidermoid cyst. In the 2 patients (9%) with imprecise diagnosis at percutaneous biopsy, the malignant tumor was a melanoma and the carcinoma an adenocarcinoma. 5 . Coronal T1-weighted MR image with Gd enhancement showing a lesion in the right cavernous sinus with extension to the pterygomaxillary fossa. This lesion was found to be an adenocarcinoma at percutaneous biopsy and was treated using chemotherapy.
Five (12%) of the biopsies in the 43 patients corresponded to an indication for medical treatment, due to a diagnosis of sinusitis in 2, osteitis in 1, Wegener syndrome in 1, and Tolosa-Hunt in 1. It should be noted that biopsy results revealed inflammatory tissue in these 5 patients.
The diagnosis was finalized according to the clinical and radiological features present. These 5 patients completely recovered after their treatment.
Ten (23%) of the 43 patients benefited from oncological treatment, based on the diagnosis of carcinoma in 6, adenocarcinoma in 2, and lymphoma in 2. Among these 10 patients, 6 underwent an extracranial surgical procedure during the course of their treatment. Histopathological examination showed carcinoma in 3, adenocarcinoma in 1, and lymphoma in 2, which confirmed the pathological diagnosis made at percutaneous biopsy.
In 4 (9%) of the 43 patients, treatment was conservative, as diagnosed tumors were meningiomas and their mass was enclosed within the parasellar lodge dural limits, and quiescent. No imaging or clinical evolution of these 4 cases was observed up to the present time.
Diagnostic Accuracy
Among the 50 patients studied, diagnosis at percutaneous biopsy was reappraised during the second open surgery in 28 patients (56%), which allowed us to evaluate the diagnostic accuracy of this procedure. This 28-patient group included the 22 with productive percutaneous biopsy and the 6 who underwent additional surgery on another localization of their malignant disease, outside the brain.
Sensitivity of the percutaneous biopsy to distinguish between benign and malignant tumors was 0.83 (95% CI 0.52-0.98) and the specificity was 1 (95% CI 0.79-1). The posttest probabilities of risk of malignant tumor if the biopsy indicated a malignant tumor according to the pretest probabilities are shown in Fig. 7 . The histopathological concordance between the reference standard and the biopsy is shown in Table 2 and the k coefficient was 0.81. 
Meningeal Cells
Meningeal cells were found at percutaneous biopsy in 14 patients, and histopathological diagnosis at second open surgery identified meningiomas in 10 (71%) of them. The 4 others were diagnosed as rhabdomyosarcoma, sarcoma, lymphoma, and plasmacytoma.
Morbidity
Two surgical complications occurred in this series (4%): face cellulitis in 1 case (2%) and cheek hematoma in the other (2%), but both recovered spontaneously without any sequelae. In two-thirds of the patients, the procedure was followed by some degree of hypesthesia, paresthesia, and/or dysesthesia, likely due to the biopsy needle penetrating into the foramen ovale. Fortunately, these disturbances in the mandibular territory of the trigeminal nerve were mostly transient; only 3 patients had permanent deficits.
Discussion
Our study represents the largest series of percutaneous biopsies performed through the foramen ovale of lesions located in the cavernous sinus area and surrounding area. Since its first description in 1989, 18 only series with few cases have been reported. 3, 6, 8, 15, 22 This has thus made the evaluation of its histopathological diagnostic accuracy impossible.
In the present series, the method showed a high level of accuracy: sensitivity and specificity were 83% and 100%, respectively. Sensitivity of diagnostic tests helps to rule out diseases when results are negative. In other words, if a test is highly sensitive and the result negative, the patient tested does not have the disease. Specificity helps to confirm diseases. In our series, biopsy had a valuable specificity (100%), which confirms this malignancy as an indication for chemotherapy and/or radiation therapy with a very high degree of reliability. Figure 7 shows the probability of malignancy according to percutaneous biopsy result and prebiopsy probability; this figure confirms the reliable ability to confirm malignancy.
The k coefficient was 0.81, which demonstrates excellent accuracy. Biopsy did not provide the right diagnosis of histopathological type in 5 cases ( Table 2 ). In 1 case, the biopsy indicated low-grade chondrosarcoma instead of an epidermoid cyst. This may be because the biopsy harvested cartilaginous tissue located at the skull base in the vicinity of the epidermoid cyst. In 2 cases, biopsy indicated meningioma when there was a rhabdomyosarcoma or plasmacytoma. Harvesting near the presence of meningeal hyperplasia instead of harvesting tumor tissue itself might have led to this result. In another case, biopsy indicated malignancy without being able to specify the exact histopathological diagnosis, which was determined to be a melanoma. In the last case, biopsy indicated carcinoma when it was actually an adenocarcinoma. In these last 2 cases, immunomarking was impossible due to the paucity of the sample, which only permitted a cytological examination.
Because the cavernous sinus region and its surroundings are the location of a large variety of lesions that require individual consideration regarding different therapeutic strategies, prior percutaneous biopsy has a practical usefulness. This procedure might be especially useful when clinical and imaging data are insufficiently adequate to determine a pathological diagnosis.
Various types of lesions may appear in the cavernous sinus and the surrounding area. The most frequent tumors are meningiomas, but schwannomas, dysembryoplastic (epidermoid and dermoid) tumors, chondrosarcomas, chordomas, carcinomas, metastases, and lymphomas can also be observed. Malignant tumors may be primary retrograde perineural extensions of carcinomas along the trigeminal nerve, due to subarachnoid dissemination, or metastases from extracranial malignancies. 5 In our series the prevalence of malignancies was 40% in those lesions that were confirmed by histopathological diagnosis at second open surgery. This is comparable to the results in the study by Sekhar et al.
14 who reported 137 cavernous sinus lesions containing 37% of malignant lesions. However, the prevalence of patients with malignancy may be more important in our series than in reality because we chose to investigate patients for whom imaging did not provide sufficient information or who had atypical images that corresponded more typically with malignancy. Furthermore, nontumorous processes such as inflammatory processes may also develop inside the cavernous sinus or Meckel cave. 1, 4, 9 Percutaneous biopsy in the parasellar region and surrounding area uses the same approach as that used for the percutaneous treatment of trigeminal neuralgia, which was first described by Härtel for alcohol injection, 11 then applied for all types of percutaneous lesioning techniques. 17, 19, 20 The trajectory of the needle through the foramen ovale limits targeting to the Meckel cave, the posterior sector of the cavernous sinus, and the upper part of the petroclival region. In our series, percutaneous biopsy allowed us to define the management in 78% of cases. The method can be considered as a minimally invasive surgical tool, and complications are uncommon.
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In our series, we only experienced 2 transient complications. Facial cellulitis was a nonspecific complication; the cheek hematoma, which spontaneously recovered, was likely due to vascular injury of the maxillary artery in the pterygomaxillary fossa.
2 It also should be noted that we experienced no injury of the ICA. Nevertheless, we recommend performing DS angiography, or at least arterial MR angiography or arterial CT angiography before initiating biopsy.
The major limitation of percutaneous biopsy is the difficulty in obtaining specimen fragments in sufficient quantity and quality to allow cytopathological examination, and even more importantly, histopathological examination. Therefore, it is very important to have a close cooperation and dialogue between the neurosurgeon and pathologist during the biopsy procedure, so as to increase the probability of having enough tissue material for reliable examination. Another problem is the relatively high frequency of meningeal cell presence in the harvested fragments, which do not always correspond with meningiomas. This is likely due to catching some fragments of the meninges during the biopsy technique and also to the possible presence of arachnoid cells inside the cavernous sinus and Meckel cave.
Conclusions
This study demonstrates the usefulness of percutaneous biopsy of the parasellar region and surroundings through the foramen ovale, in the presence of masses when imaging does not provide sufficient information on their histopathological nature. When dealing with such lesions, it is of paramount importance to avoid unnecessary open surgery, but equally to be certain of the correct pathological diagnosis. Inflammatory pseudotumors have their specific treatments. Most malignant tumors can be treated by chemotherapy and/or radiation therapy, 7 provided malignant criteria and histological type have been established.
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